BCL2L1 and Thrombocytopenia: BCL-XL is also required for megakaryocytes survival, and disabling BCL-XL leads to a decrease in platelets production, which can potentially cause thrombocytopenia [33,34], and (b) lack of obatoclax specificity as obatoclax can also dysregulate the activity of many survival factors.